Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization.

Zech HB, Schafhausen P, Ramke L, Velthaus JL, Kreutzfeldt S, Hübschmann D, Rothkamm K, Bokemeyer C, Hoffmann AS, Fröhling S, Glimm H, Betz CS, Kriegs M, Christopeit M

Open source

DOI
10.3390/biomedicines13051266
Published
2025 May 21
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines13051266,
  title = {Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization.},
  author = {Zech HB and Schafhausen P and Ramke L and Velthaus JL and Kreutzfeldt S and Hübschmann D and Rothkamm K and Bokemeyer C and Hoffmann AS and Fröhling S and Glimm H and Betz CS and Kriegs M and Christopeit M},
  year = {2025},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines13051266},
  url = {https://doi.org/10.3390/biomedicines13051266}
}

RIS

TY  - JOUR
TI  - Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization.
AU  - Zech HB
AU  - Schafhausen P
AU  - Ramke L
AU  - Velthaus JL
AU  - Kreutzfeldt S
AU  - Hübschmann D
AU  - Rothkamm K
AU  - Bokemeyer C
AU  - Hoffmann AS
AU  - Fröhling S
AU  - Glimm H
AU  - Betz CS
AU  - Kriegs M
AU  - Christopeit M
PY  - 2025
JO  - Biomedicines
DO  - 10.3390/biomedicines13051266
UR  - https://doi.org/10.3390/biomedicines13051266
ER  - 

APA

HB, Z., P, S., L, R., JL, V., S, K., D, H., K, R., C, B., AS, H., S, F., H, G., CS, B., M, K., & M, C. (2025). Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization.. Biomedicines. https://doi.org/10.3390/biomedicines13051266

Source records